Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India

Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India

Introduction: Multidrug resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is a leading cause of death in India. To combat this, National TB Elimination Programme, erstwhile RNTCP) has launched “shorter oral bedaquiline (Bdq)-containing MDR/RR-TB regimen” from March 2021 replacing the injectabl...

Full description

Saved in:
Bibliographic Details
Main Authors: Hindol Mondal, Manasi Basu Banerjee, Abheek Das, Somnath Maity
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-07-01
Series:Journal of Advanced Lung Health
Subjects:
adverse events
bedaquiline
multidrug-resistant/rifampicin-resistant tuberculosis
Online Access:https://journals.lww.com/10.4103/jalh.jalh_64_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items